Cerus Corp (CERS) Stock Price, Quote & News

Latest News on CERS

Apr 17, 2025, 8:30 AM EDT - 8 days ago

Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

Mar 5, 2025, 1:00 PM EST - 7 weeks ago

Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)

Feb 20, 2025, 9:50 PM EST - 2 months ago

Cerus Corporation (CERS) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:00 PM EST - 2 months ago

Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

Feb 19, 2025, 4:00 PM EST - 2 months ago

Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 7, 2025, 8:30 AM EST - 2 months ago

Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025

Jan 13, 2025, 8:30 AM EST - 3 months ago

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update

Nov 13, 2024, 8:30 AM EST - 5 months ago

Cerus Corporation to Participate in Upcoming Investor Conferences

Oct 30, 2024, 11:52 PM EDT - 6 months ago

Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 4:00 PM EDT - 6 months ago

Cerus Corporation Announces Third Quarter 2024 Financial Results

Oct 18, 2024, 8:30 AM EDT - 6 months ago

Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024

Oct 18, 2024, 8:30 AM EDT - 6 months ago

Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting

Oct 16, 2024, 4:00 PM EDT - 6 months ago

Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe

Aug 1, 2024, 8:29 PM EDT - 9 months ago

Cerus Corporation (CERS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 4:00 PM EDT - 9 months ago

Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range

Jul 18, 2024, 8:30 AM EDT - 10 months ago

Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024

Jul 2, 2024, 4:00 PM EDT - 10 months ago

Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors

Jun 21, 2024, 8:30 AM EDT - 11 months ago

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion

Jun 14, 2024, 8:30 AM EDT - 11 months ago

Cerus Corporation Celebrates World Blood Donor Day 2024

May 22, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference

May 2, 2024, 7:37 PM EDT - 1 year ago

Cerus Corporation (CERS) Q1 2024 Earnings Call Transcript

May 2, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces First Quarter 2024 Financial Results

Apr 18, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024

Mar 26, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life

Mar 19, 2024, 8:00 AM EDT - 1 year ago

Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients

Mar 5, 2024, 6:43 PM EST - 1 year ago

Cerus Corporation (CERS) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 4:00 PM EST - 1 year ago

Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results

Feb 20, 2024, 8:30 AM EST - 1 year ago

Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024

Jan 8, 2024, 8:30 AM EST - 1 year ago

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update

Nov 2, 2023, 10:52 PM EDT - 1 year ago

Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces Third Quarter 2023 Financial Results

Nov 1, 2023, 2:46 PM EDT - 1 year ago

Bloodbuy Announces Agreement with Cerus Corporation to Offer Pathogen Reduced Cryoprecipitated Fibrinogen Complex on its Digital Marketplace

Oct 19, 2023, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023

Oct 10, 2023, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting

Sep 27, 2023, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer

Sep 12, 2023, 8:30 AM EDT - 1 year ago

Cerus Corporation to Participate in the 2023 Cantor Global Healthcare Conference

Aug 2, 2023, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces Second Quarter 2023 Financial Results

Jul 19, 2023, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023

Jun 15, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation Announces Symposium and Abstracts at the 33rd Regional ISBT Congress

Jun 14, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation Celebrates World Blood Donor Day 2023

Jun 5, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation Announces Follow-on Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate

May 10, 2023, 3:41 PM EDT - 2 years ago

Cerus Corporation: Cash Burn Remains Concerning

May 4, 2023, 9:10 PM EDT - 2 years ago

Cerus Corporation (CERS) Q1 2023 Earnings Call Transcript

May 4, 2023, 4:00 PM EDT - 2 years ago

Cerus Corporation Announces First Quarter 2023 Financial Results

Apr 20, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023

Feb 28, 2023, 11:51 PM EST - 2 years ago

Cerus Corp (CERS) Q4 2022 Earnings Call Transcript

Feb 28, 2023, 4:00 PM EST - 2 years ago

Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results

Feb 15, 2023, 8:30 AM EST - 2 years ago

Cerus Corporation to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

Jan 9, 2023, 8:30 AM EST - 2 years ago

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update

Nov 3, 2022, 5:50 PM EDT - 2 years ago

Market Cap	252.67M
Revenue (ttm)	201.32M
Net Income (ttm)	-20.92M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-10.39%
Debt to Equity Ratio	1.48

Volume	1,297,800
Avg Vol	1,416,134
Day's Range	N/A - N/A
Shares Out	185.79M
Stochastic %K	48%
Beta	1.70
Analysts	Strong Sell
Price Target	$4.25